-
1
-
-
38049066236
-
Insulin regimens for type 2 diabetes mellitus
-
Brunton S Insulin regimens for type 2 diabetes mellitus. J Fam Pract 2006, 55:10S-107.
-
(2006)
J Fam Pract
, vol.55
-
-
Brunton, S.1
-
3
-
-
33845965337
-
Intermediate and long-acting insulin: a review of NPH insulin, insulin glargine and insulin detemir
-
Peterson GE Intermediate and long-acting insulin: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin 2006, 22:2613-2619.
-
(2006)
Curr Med Res Opin
, vol.22
, pp. 2613-2619
-
-
Peterson, G.E.1
-
4
-
-
33845236398
-
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
-
Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 2006, 28:1569-1581.
-
(2006)
Clin Ther
, vol.28
, pp. 1569-1581
-
-
Philis-Tsimikas, A.1
Charpentier, G.2
Clauson, P.3
Ravn, G.M.4
Roberts, V.L.5
Thorsteinsson, B.6
-
5
-
-
50049118914
-
Long-acting insulin analogs versus human insulins
-
Garg SK, Naik RG Long-acting insulin analogs versus human insulins. Diabetes Techn Ther 2008, 10:331-332.
-
(2008)
Diabetes Techn Ther
, vol.10
, pp. 331-332
-
-
Garg, S.K.1
Naik, R.G.2
-
6
-
-
0242269000
-
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
-
Riddle MC, Rosenstock J, Gerich J The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003, 26:3080-3086.
-
(2003)
Diabetes Care
, vol.26
, pp. 3080-3086
-
-
Riddle, M.C.1
Rosenstock, J.2
Gerich, J.3
-
7
-
-
33746391488
-
A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy as oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes
-
Hermansen K, Davies M, Derezinski T, Ravn GM, Clauson P, Home P A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy as oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetes Care 2006, 29:1269-1274.
-
(2006)
Diabetes Care
, vol.29
, pp. 1269-1274
-
-
Hermansen, K.1
Davies, M.2
Derezinski, T.3
Ravn, G.M.4
Clauson, P.5
Home, P.6
-
8
-
-
39049105019
-
A randomised 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes
-
Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G A randomised 52 week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetologia 2008, 51:408-416.
-
(2008)
Diabetologia
, vol.51
, pp. 408-416
-
-
Rosenstock, J.1
Davies, M.2
Home, P.D.3
Larsen, J.4
Koenen, C.5
Schernthaner, G.6
-
9
-
-
15944382350
-
Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes
-
Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A Reduced hypoglycaemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005, 28:950-955.
-
(2005)
Diabetes Care
, vol.28
, pp. 950-955
-
-
Rosenstock, J.1
Dailey, G.2
Massi-Benedetti, M.3
Fritsche, A.4
Lin, Z.5
Salzman, A.6
-
10
-
-
34547830134
-
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
-
Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007, 2. CD005613.
-
(2007)
Cochrane Database Syst Rev
, vol.2
-
-
Horvath, K.1
Jeitler, K.2
Berghold, A.3
Ebrahim, S.H.4
Gratzer, T.W.5
Plank, J.6
-
11
-
-
47649100195
-
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes. A meta-analysis
-
Monami M, Marchionni N, Mannucci E Long-acting insulin analogues versus NPH human insulin in type 2 diabetes. A meta-analysis. Diabetes Res Clin Pract 2008, 81:184-189.
-
(2008)
Diabetes Res Clin Pract
, vol.81
, pp. 184-189
-
-
Monami, M.1
Marchionni, N.2
Mannucci, E.3
-
12
-
-
22144484165
-
Systemic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus
-
Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, et al. Systemic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005, 165:1337-1344.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1337-1344
-
-
Plank, J.1
Siebenhofer, A.2
Berghold, A.3
Jeitler, K.4
Horvath, K.5
Mrak, P.6
-
13
-
-
34249807045
-
When basal insulin therapy in type 2 diabetes mellitus is not enough -what next?
-
Raccah D, Bretzel RG, Owens D, Riddle M When basal insulin therapy in type 2 diabetes mellitus is not enough -what next?. Diabetes Metab Res Rev 2007, 23:257-264.
-
(2007)
Diabetes Metab Res Rev
, vol.23
, pp. 257-264
-
-
Raccah, D.1
Bretzel, R.G.2
Owens, D.3
Riddle, M.4
-
14
-
-
62549083402
-
Safety and effectiveness of biphasic insulin aspart 30/70 (NOVOMIX 30) when switching from human penmix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE(tm) observational study
-
Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. Safety and effectiveness of biphasic insulin aspart 30/70 (NOVOMIX 30) when switching from human penmix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE(tm) observational study. Int J Clin Pract 2009, 63:574-582.
-
(2009)
Int J Clin Pract
, vol.63
, pp. 574-582
-
-
Shah, S.1
Benroubi, M.2
Borzi, V.3
Gumprecht, J.4
Kawamori, R.5
Shaban, J.6
-
15
-
-
70349675747
-
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes
-
Lingvay L, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes. Diabetes Care 2009, 32:1789-1795.
-
(2009)
Diabetes Care
, vol.32
, pp. 1789-1795
-
-
Lingvay, L.1
Legendre, J.L.2
Kaloyanova, P.F.3
Zhang, S.4
Adams-Huet, B.5
Raskin, P.6
|